EDGAR Filing Documents for 0001193125-23-248461

Form 8-K - Current report:

SEC Accession No. 0001193125-23-248461

Filing Date

2023-10-02

Accepted

2023-10-02 08:30:29

Documents

Period of Report

2023-09-27

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d561858d8k.htm iXBRL	8-K	42945
2	EX-10.1	d561858dex101.htm	EX-10.1	69057
3	EX-10.2	d561858dex102.htm	EX-10.2	68646
4	EX-10.3	d561858dex103.htm	EX-10.3	87010
5	EX-10.4	d561858dex104.htm	EX-10.4	55388
6	EX-99.1	d561858dex991.htm	EX-99.1	14427
10	GRAPHIC	g561858g0929220803940.jpg	GRAPHIC	2092
	Complete submission text file	0001193125-23-248461.txt		553786

Data Files

Seq	Description	Document	Type	Size
7	XBRL TAXONOMY EXTENSION SCHEMA	aadi-20230927.xsd	EX-101.SCH	2841
8	XBRL TAXONOMY EXTENSION LABEL LINKBASE	aadi-20230927_lab.xml	EX-101.LAB	17994
9	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	aadi-20230927_pre.xml	EX-101.PRE	11255
12	EXTRACTED XBRL INSTANCE DOCUMENT	d561858d8k_htm.xml	XML	3364

Mailing Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272

Business Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272 424-473-8055

Aadi Bioscience, Inc. (Filer) CIK: 0001422142 (see all company filings)